Rapidly progressive multidrug-resistant tuberculosis (MDR-TB) is well docum
ented in human immunodeficiency virus (HIV) positive subjects, but it is no
t fully recognised in HN-negative subjects in the familial environment. We
report three cases of MDR-TB in three young HIV-negative subjects from the
same family. All the patients showed signs of meningitis during the course
of their disease, and in two cases a resistant strain of Mycobacterium tube
rculosis was isolated in cerebrospinal fluid. Two of the three subjects die
d from neurological complications; the other was successful treated utilisi
ng both systemic and intrathecal therapy for tuberculous meningitis. By a r
etrospective analysis of DNA obtained from Lowenstein-Jensen cultures, the
strains were confirmed as M. tuberculosis resistant to rifampicin and isoni
azid, and were closely related in the two cases where specimens were availa
ble for analysis. The resistance was acquired in two patients initially inf
ected with a susceptible strain; in the other patient, the resistance was p
resent on the first sensitivity test for which results were available. This
report demonstrates the high risk of fatality from MDR-TB for HIV-negative
subjects in the absence of reliable early diagnostic and preventive tools.
It also reinforces the concept that genetic susceptibility to M. tuberculo
sis may be an important factor in the clinical presentation and outcome of
MDR-TB.